Adaptive Biotechnologies
Price & Volume
Stats
See moreOpen | $6.96 |
Previous Close | $6.83 |
Day Range | $6.96-$7.18 |
52W Range | $2.48-$9.01 |
Market Cap | $1B |
Shares Short | 10M |
Financials
See moreRevenue (12 Mos) | $178.9M |
Revenue Growth (YoY) | 3.7% |
Gross Profit (12 Mos) | $89.7M |
Diluted EPS | -$1.08 |
News
See moreYahoo Finance • 12 days ago
Adaptive Biotechnologies to Report First Quarter 2025 Financial Results on May 1, 2025
Yahoo Finance • last month
Adaptive Biotechnologies Launches Assay Enhancements to Increase clonoSEQ® Sensitivity for Clinical MRD Detection in Diffuse Large B-Cell Lymphoma
Yahoo Finance • 2 months ago
Adaptive Biotechnologies Reports Fourth Quarter and Full Year 2024 Financial Results
Yahoo Finance • 11 months ago
ARK Invest's Cathie Wood Snags These 3 Bargains — Are They Right for Your Portfolio?
About
CEO | Mr. Chad M. Robins M.B.A. |
CFO | Mr. Kyle Piskel |
Address | 1165 Eastlake Avenue East, Seattle, WA, United States, 98109 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 619 |
